EIPICO targets EGP 6.5B in sales for 2024

Updated 2/11/2024 1:02:00 PM
EIPICO targets EGP 6.5B in sales for 2024

Arab Finance: Egyptian International Pharmaceutical Industries Co. (EIPICO) is aiming to achieve sales of more than EGP 6.5 billion this year, according to a press release on February 11th.

The firm’s preliminary financial results showed that EIPICO achieved over EGP 5 million in sales last year.

the results also revealed that EIPICO's exports stood at $54 million in 2023, making up a market share of 26% out of the total Egyptian exports.

EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry. It is a manufacturer and exporter of pharmaceuticals and holds license agreements with a group of international.

Related News